GENOPIA BIOMEDICAL GMBH has a total of 22 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are JOHNS HOPKINS UNIV SCHOOL OF M, ONCOTHERAPY SCIENCE LTD and NATIONWIDE CHILDREN S HOSPITAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Australia | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | Germany | 2 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Measuring microorganism processes | |
#5 | Therapeutic chemical compounds | |
#6 | Enzymes | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Voelkel Helge | 10 |
#2 | Volkel Helge | 7 |
#3 | Linder Juergen | 6 |
#4 | Schultz Joachim E | 5 |
#5 | Schultz Joachim | 4 |
#6 | Linder Jurgen | 3 |
#7 | Voelkel Helge Dr | 2 |
#8 | Linder Juergen Dr | 1 |
#9 | Schultz Joachim E Prof Dr | 1 |
Publication | Filing date | Title |
---|---|---|
WO03040295A2 | Ion channel | |
DE10155738A1 | New protein with adenylate cyclase and ion-channel domains, useful for developing therapeutic agents against e.g. malaria, also related nucleic acid | |
DE10155736A1 | New protein with adenylate cyclase and ion-channel domains, useful for developing therapeutic agents against e.g. malaria, also related nucleic acid | |
EP1281773A1 | Method to detect splice variants of the calcineurin gene | |
EP1281756A1 | Regulator of calcineurin | |
EP1258528A1 | Expression of membrane proteins using an adenylyl cyclase of Mycobacterium tuberculosis | |
EP1100912A1 | Method for screening of modulators of calcineurin activity |